Angiogenesis inhibitors under study for the treatment of lung cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 41, 63-72
- https://doi.org/10.1016/s0169-5002(03)00144-2
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancerBritish Journal of Cancer, 2001
- Development of Matrix Metalloproteinase Inhibitors in Cancer TherapyJNCI Journal of the National Cancer Institute, 2001
- Angiogenesis: regulators and clinical applicationsBiochemical Pharmacology, 2001
- Tumor angiogenesis: past, present and the near futureCarcinogenesis: Integrative Cancer Research, 2000
- Angiogenesis and non-small cell lung cancerLung Cancer, 2000
- Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and ProgestinsMolecular Endocrinology, 1999
- Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding ActivityCell, 1998
- Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 1996
- Current approaches to targeting cancer using antiangiogenesis therapiesCancer Treatment Reviews, 1994
- Endothelial proliferation in tumours and normal tissues: Continuous labelling studiesBritish Journal of Cancer, 1984